In psoriasis-like mice models, glabridin could enhance the activities of SOD, CAT and GSH, and lower the levels of MDA and pro-inflammatory cytokines to mitigate the inflammation and histopathological alterations i.e. a glabridin-dose-dependent reduction of epidermal thickness and lymphocyte infiltration in the dermis [71]; therefore, glabridin is an effective anti-psoriasis bioactive compound. Here, CAT is linked to psoriasis.